Thursday, October 16, 2025 · 11:00 a.m. Eastern Time (US & Canada) (GMT -4:00)
Successful antibody discovery requires more than just access to powerful platforms - it demands the experience to apply them efficiently and strategically. In this webinar, we present Biointron’s proven expertise in two discovery approaches: VHH Phage Display for single-domain antibody generation and AbDrop® Single B Cell Screening for rapid antibody discovery.
Representative case studies will be discussed to illustrate how Biointron’s seasoned scientific team overcomes technical hurdles, tackles challenging targets, shortens discovery timelines, and consistently delivers high-quality antibodies, thus offering a reliable path from target to candidate.
Major antibody discovery approaches overview.
Introduction of Biointron Phage Display VHH antibody discovery solution and case studies.
Introduction of Biointron AbDrop antibody discovery solution and case studies.
Summary & Biointron at a glance.
Gang Liu, PhD, Director of Discovery Services at Biointron
Dr. Gang Liu has devoted himself to biological sciences and antibody therapeutics research for more than 20 years. Before joining Biointron, Dr. Liu worked in renowned biotech such as Genscript, and prestigious academia institutions, including Childrens Hospital LA, UC Irvine, and City of Hope Medical Center. Dr. Liu earned his Ph.D. degree from Academy of Military Medical Sciences in China, 2007, specializing in cancer research.
AI is transforming antibody discovery, but better models only come from better d……
The antibody therapeutics sector is rapidly evolving, transitioning from traditi……
Biointron’s 2026 Lunch & Learn, held at CIC Cambridge on May 8, 2026, featured e……
ScientistとScience Exchangeとのご利用可能です。
